Patent intelligence · DE
DE 102006048130
Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil
Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil
Patent details — DE 102006048130
- Jurisdiction
- DE
- Status
- granted
- Grant date
- Apr 10, 2008
- Expiration
- Apr 5, 2028
- Applicant
- AXXONIS PHARMA AG [DE]
- CPC classes
- A61K 9/ 00 A I, A61K 31/ 48 A I, A61K/3148, A61K/97061
Quick answer
DE 102006048130 (Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil) is held by AXXONIS PHARMA AG [DE]. Status: granted. Granted Apr 10, 2008. Expires Apr 5, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AXXONIS PHARMA AG [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 31/ 48 A I, A61K/3148, A61K/97061, A61P/2500, A61P/2514
More from AXXONIS PHARMA AG [DE]
Related pharmaceutical patents in our USPTO index.
-
CA 2626142
SOLUTIONS AQUEUSES STABILISEES DE COMPOSES D'ERGOLINE
granted -
IT MI20070164
CEROTTO TRANSDERMICO
granted -
DE 102004006048
Pharmazeutische Kombination aus Gadolinium Komplexen und kolloidalen Biopolymeren und deren Verwendung als kontrastverstärkendes Mittel zur i.v. Injektion bzw. i.v. Infusion in der MR Angiographie
expired -
DE 10341317
Mittel zur transdermalen Applikation
expired -
AU 2002363847
1-ALLYL ERGOT ALKALOID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF FOR PREVENTING AND TREATING MIGRAINE
expired -
EP 1311248
TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR BEHANDLUNG DES RESTLESS-LEGS-SYNDROMS
expired -
EP 1303278
KOMBINATION EINES TRANSDERMALEN THERAPEUTISCHEN SYSTEMS UND EINER ORALEN UND/ODER PARENTERALEN ZUBEREITUNG ENTHALTEND DOPAMINAGONISTEN ZUR BEHANDLUNG DOPAMINERGER ERKRANKUNGEN
expired
Frequently asked questions
What is US patent 102006048130?
DE 102006048130 (Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil) is held by AXXONIS PHARMA AG [DE]. Status: granted. Granted Apr 10, 2008. Expires Apr 5, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns DE 102006048130?
AXXONIS PHARMA AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does DE 102006048130 expire?
Our index shows an expiration date of Apr 5, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.